Cite

HARVARD Citation

    Sacco, R. et al. (n.d.). OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB. Digestive and liver disease. pp. S119-S120. [Online]. 
  
Back to record